Staff20192020202120222023
Personnel at the end of the year1,0111,2201,5691,8472,075
Staff turnover in EUR693,383793,493675,794652,058866,871
Turnover LabelEUREUREUREUREUR
The share: stated in EUR20192020202120222023
Shares outstanding (in mn.)0.270.350.3620.200.40
Dividend per share-----
Basic earnings per share-2.78-1.17-4.15-4.32-0.73
P/L in EUR million under IAS/IFRS20192020202120222023
Turnover701.0968.11,060.31,204.41,798.8
Operating income (EBIT)-33.4-1.4-64.3-70.20.9
Earnings before taxes-42.3-16.0-77.5-84.5-14.6
Annual net profit/ loss-36.3-16.8-74.2-77.6-12.0
Balance sheet in EUR million under IAS/IFRS20192020202120222023
Assets
Total current assets210.8254.1432.8343.9499.5
Total fixed assets223.5289.8360.0398.4549.2
Total assets434.3543.9792.7742.41,048.7
Liabilities
Total short-term liabilities59.874.6124.1119.3223.7
Total long-term liabilities141.844.2253.2268.4304.7
Total provisions0.00.00.00.04.5
Equity capital232.8425.1415.4354.6520.3
Total liabilities434.3543.9792.7742.41,048.7
Management:
Stefan Feltens
Jasper Eenhorst
Marc Fischer
Stephan Weber
Theresa Holler
Board:
Björn H. Söder
Frank Köhler
Henriette Peucker
Jaska Marianne de Bakker
Jérôme Cochet
Shareholding in %:
Capital Research & Management Co. (World Investors) 4.81
Christoph Laubmann 4.18
DWS Investment GmbH 3.09
ETHENEA Independent Investors SA 4.09
Frank Köhler 3.08
Galenica AG 7.88
Michael Köhler 7.23
Robert Hess 3.22
Sylebra Capital Ltd. 3.00
T. Rowe Price International Ltd. 2.94
Freefloat 56.49
Address: Erik de Rodeweg 11/13, 5975 WD Sevenum
T: +
F: +
I: http://www.redcare-pharmacy.com
E: because-we-care@redcare-pharmacy.com